Your partner across the entire development journey
As early diagnosis and personalized treatment become increasingly important, Fujirebio brings unique value through its comprehensive Neuro Expert Toolbox (NExT).
This innovative concept enables partners and customers to access Fujirebio’s expertise at every stage of biomarker development – from initial concept to validated diagnostic solutions.
Partnerships
We share our expertise with different types of partners at every step of the development process. From access to our proprietary antibodies and assay development support to full-scale manufacturing, we offer flexible partnership models that can be tailored to your needs.
CDMO services
Our CDMO services, in particular, provide our partners a unique set of resources and solutions to facilitate cost-efficient biomarker development and manufacturing.
CDMO = Contract Development and Manufacturing Organization
(Custom assay design)
(Xplorer assays)
(Research use only assays)
(Diagnostic solutions)
Concept chamber(Custom assay design)
Early research and development
We share our expertise with different types of partners at every step of the development process. From access to our proprietary antibodies and assay development support to full-scale manufacturing, we offer flexible partnership models that can be tailored to your needs.
Explorer chamber(Xplorer assays)
Exploration phase
Our advanced Xplorer kits enable rapid evaluation of novel biomarkers’ clinical potential. This accelerates the pathway from discovery to application, helping pharmaceutical companies and research institutions make faster, more informed decisions about biomarker capability.
Incubation chamber(Research use only assays)
Development and validation
Our fully automated Lumipulse platform provides exceptional precision and reliability, ensuring consistent results across multiple testing sites. This robust technology foundation is crucial for establishing clinical validity and utility of new biomarkers solutions.
Routine chamber(Diagnostic solutions)
Routine clinical implementation
When biomarkers prove their value, Fujirebio's regulatory expertise and global reach enable broad market access. Our track record of succesful IVD product development and commercialization is unmatched in the neuro field.
Why Fujirebio?
For over three decades, Fujirebio has been at the forefront of neurological disease testing, pioneering breakthrough solutions that have transformed our understanding and diagnosis of neurological conditions.
Today, as the field enters an exciting new era of precision medicine for better patient outcomes, Fujirebio stands as the trusted expert partner in neuro diagnostics, offering unmatched capabilities from early biomarker research to routine clinical testing.
Our Doors Are Open
Contact us
At Fujirebio we encourage partnerships dedicated to advancing testing for neurological diseases.
